Shenzhen Hightide Biopharmaceutical Ltd.
Clinical trials sponsored by Shenzhen Hightide Biopharmaceutical Ltd., explained in plain language.
A Chinese biopharmaceutical company focused on drugs for infectious and metabolic diseases.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
-
New diabetes drug HTD1801 put to the test in 551-Person trial
Disease control CompletedThis Phase 3 trial tested whether HTD1801 (berberine ursodeoxycholate) can help people with type 2 diabetes who aren't well controlled on metformin alone. Over 500 participants received either the drug or a placebo for 24 weeks. The main goal was to see if the drug lowered blood …
Phase 3 • Sponsor: Shenzhen HighTide Biopharmaceutical Ltd. • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New diabetes pill takes on popular drug in Head-to-Head trial
Disease control CompletedThis study tested a new drug called HTD1801 (berberine ursodeoxycholate) against the standard diabetes drug dapagliflozin in 367 adults with type 2 diabetes whose blood sugar was not well controlled by metformin alone. The main goal was to see how well HTD1801 lowers blood sugar …
Phase 3 • Sponsor: Shenzhen HighTide Biopharmaceutical Ltd. • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New pill could help millions with uncontrolled diabetes
Disease control CompletedThis Phase 3 trial tested whether HTD1801, a new drug made from a modified natural compound, can lower blood sugar in people with type 2 diabetes who struggle to control it with diet and exercise alone. The study enrolled 408 adults and compared the drug to a placebo over 24 week…
Phase 3 • Sponsor: Shenzhen HighTide Biopharmaceutical Ltd. • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Can a new pill tame blood sugar in type 2 diabetes?
Disease control CompletedThis clinical trial is testing an investigational drug called HTD1801 (berberine ursodeoxycholate) to see if it can improve blood sugar control in adults with type 2 diabetes that is not well managed by diet and exercise alone. The study will compare the drug against a placebo ov…
Phase 2 • Sponsor: Shenzhen HighTide Biopharmaceutical Ltd. • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC